-
1
-
-
65249151382
-
Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41
-
Anastassopoulou, C. G., T. J. Ketas, P. J. Klasse, and J. P. Moore. 2009. Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41. Proc. Natl. Acad. Sci. U. S. A. 106:5318-5323.
-
(2009)
Proc. Natl. Acad. Sci. U. S. A.
, vol.106
, pp. 5318-5323
-
-
Anastassopoulou, C.G.1
Ketas, T.J.2
Klasse, P.J.3
Moore, J.P.4
-
2
-
-
33846574670
-
Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652
-
Baba, M., H. Miyake, X. Wang, M. Okamoto, and K. Takashima. 2007. Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652. Antimicrob. Agents Chemother. 51:707-715.
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 707-715
-
-
Baba, M.1
Miyake, H.2
Wang, X.3
Okamoto, M.4
Takashima, K.5
-
3
-
-
2142768792
-
Long-term persistence of HIV-1 vaccine-induced CD4+CD45RA-CD62L-CCR7- Memory T-helper cells
-
Balla-Jhagjhoorsingh, S. S., G. Koopman, P. Mooij, W. Koornstra, S. McCormack, J. Weber, G. Pantaleo, and J. L. Heeney. 2004. Long-term persistence of HIV-1 vaccine-induced CD4+CD45RA-CD62L-CCR7- memory T-helper cells. AIDS 18:837-848.
-
(2004)
AIDS
, vol.18
, pp. 837-848
-
-
Balla-Jhagjhoorsingh, S.S.1
Koopman, G.2
Mooij, P.3
Koornstra, W.4
McCormack, S.5
Weber, J.6
Pantaleo, G.7
Heeney, J.L.8
-
4
-
-
0036838693
-
Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding
-
Basmaciogullari, S., G. J. Babcock, D. Van Ryk, W. Wojtowicz, and J. Sodroski. 2002. Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding. J. Virol. 76:10791-10800.
-
(2002)
J. Virol.
, vol.76
, pp. 10791-10800
-
-
Basmaciogullari, S.1
Babcock, G.J.2
Van Ryk, D.3
Wojtowicz, W.4
Sodroski, J.5
-
5
-
-
70049098271
-
Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry
-
Berro, R., R. W. Sanders, M. Lu, P. J. Klasse, and J. P. Moore. 2009. Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry. PLoS Pathog. 5:e1000548.
-
(2009)
PLoS Pathog.
, vol.5
-
-
Berro, R.1
Sanders, R.W.2
Lu, M.3
Klasse, P.J.4
Moore, J.P.5
-
6
-
-
0033989709
-
The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosis
-
Blanco, J., J. Barretina, G. Henson, G. Bridger, E. De Clercq, B. Clotet, and J. A. Este. 2000. The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosis. Antimicrob. Agents Chemother. 44:51-56.
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 51-56
-
-
Blanco, J.1
Barretina, J.2
Henson, G.3
Bridger, G.4
De Clercq, E.5
Clotet, B.6
Este, J.A.7
-
7
-
-
0031042433
-
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
-
Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 94:1925-1930.
-
(1997)
Proc. Natl. Acad. Sci. U. S. A.
, vol.94
, pp. 1925-1930
-
-
Bleul, C.C.1
Wu, L.2
Hoxie, J.A.3
Springer, T.A.4
Mackay, C.R.5
-
8
-
-
0032577550
-
HIV entry and its inhibition
-
Chan, D. C., and P. S. Kim. 1998. HIV entry and its inhibition. Cell 93:681-684.
-
(1998)
Cell
, vol.93
, pp. 681-684
-
-
Chan, D.C.1
Kim, P.S.2
-
9
-
-
13844302894
-
Structure of an unliganded simian immunodeficiency virus gp120 core
-
Chen, B., E. M. Vogan, H. Gong, J. J. Skehel, D. C. Wiley, and S. C. Harrison. 2005. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 433:834-841.
-
(2005)
Nature
, vol.433
, pp. 834-841
-
-
Chen, B.1
Vogan, E.M.2
Gong, H.3
Skehel, J.J.4
Wiley, D.C.5
Harrison, S.C.6
-
10
-
-
0036333648
-
The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor
-
Cormier, E. G., and T. Dragic. 2002. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J. Virol. 76:8953-8957.
-
(2002)
J. Virol.
, vol.76
, pp. 8953-8957
-
-
Cormier, E.G.1
Dragic, T.2
-
11
-
-
0035000023
-
Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes
-
Cormier, E. G., D. N. Tran, L. Yukhayeva, W. C. Olson, and T. Dragic. 2001. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes. J. Virol. 75:5541-5549.
-
(2001)
J. Virol.
, vol.75
, pp. 5541-5549
-
-
Cormier, E.G.1
Tran, D.N.2
Yukhayeva, L.3
Olson, W.C.4
Dragic, T.5
-
12
-
-
0030861238
-
Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1
-
Doranz, B. J., Z. H. Lu, J. Rucker, T. Y. Zhang, M. Sharron, Y. H. Cen, Z. X. Wang, H. H. Guo, J. G. Du, M. A. Accavitti, R. W. Doms, and S. C. Peiper. 1997. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J. Virol. 71:6305-6314.
-
(1997)
J. Virol.
, vol.71
, pp. 6305-6314
-
-
Doranz, B.J.1
Lu, Z.H.2
Rucker, J.3
Zhang, T.Y.4
Sharron, M.5
Cen, Y.H.6
Wang, Z.X.7
Guo, H.H.8
Du, J.G.9
Accavitti, M.A.10
Doms, R.W.11
Peiper, S.C.12
-
13
-
-
0034625144
-
A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
-
Dragic, T., A. Trkola, D. A. Thompson, E. G. Cormier, F. A. Kajumo, E. Maxwell, S. W. Lin, W. Ying, S. O. Smith, T. P. Sakmar, and J. P. Moore. 2000. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl. Acad. Sci. U. S. A. 97:5639-5644.
-
(2000)
Proc. Natl. Acad. Sci. U. S. A.
, vol.97
, pp. 5639-5644
-
-
Dragic, T.1
Trkola, A.2
Thompson, D.A.3
Cormier, E.G.4
Kajumo, F.A.5
Maxwell, E.6
Lin, S.W.7
Ying, W.8
Smith, S.O.9
Sakmar, T.P.10
Moore, J.P.11
-
14
-
-
0031883554
-
A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
-
Farzan, M., H. Choe, L. Vaca, K. Martin, Y. Sun, E. Desjardins, N. Ruffing, L. Wu, R. Wyatt, N. Gerard, C. Gerard, and J. Sodroski. 1998. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J. Virol. 72:1160-1164. (Pubitemid 28116898)
-
(1998)
Journal of Virology
, vol.72
, Issue.2
, pp. 1160-1164
-
-
Farzan, M.1
Choe, H.2
Vaca, L.3
Martin, K.4
Sun, Y.5
Desjardins, E.6
Ruffing, N.7
Wu, L.8
Wyatt, R.9
Gerard, N.10
Gerard, C.11
Sodroski, J.12
-
15
-
-
0037769964
-
The HIV Env-mediated fusion reaction
-
Gallo, S. A., C. M. Finnegan, M. Viard, Y. Raviv, A. Dimitrov, S. S. Rawat, A. Puri, S. Durell, and R. Blumenthal. 2003. The HIV Env-mediated fusion reaction. Biochim. Biophys. Acta 1614:36-50.
-
(2003)
Biochim. Biophys. Acta
, vol.1614
, pp. 36-50
-
-
Gallo, S.A.1
Finnegan, C.M.2
Viard, M.3
Raviv, Y.4
Dimitrov, A.5
Rawat, S.S.6
Puri, A.7
Durell, S.8
Blumenthal, R.9
-
16
-
-
33748626539
-
Differential susceptibility of naive, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission
-
Groot, F., T. M. van Capel, J. Schuitemaker, B. Berkhout, and E. C. de Jong. 2006. Differential susceptibility of naive, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission. Retrovirology 3:52.
-
(2006)
Retrovirology
, vol.3
, pp. 52
-
-
Groot, F.1
Van Capel, T.M.2
Schuitemaker, J.3
Berkhout, B.4
De Jong, E.C.5
-
17
-
-
34347379935
-
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-infected, treatment-experienced patients: AIDS clinical trials group 5211
-
Gulick, R. M., Z. Su, C. Flexner, M. D. Hughes, P. R. Skolnik, T. J. Wilkin, R. Gross, A. Krambrink, E. Coakley, W. L. Greaves, A. Zolopa, R. Reichman, C. Godfrey, M. Hirsch, and D. R. Kuritzkes. 2007. Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-infected, treatment-experienced patients: AIDS clinical trials group 5211. J. Infect. Dis. 196:304-312.
-
(2007)
J. Infect. Dis.
, vol.196
, pp. 304-312
-
-
Gulick, R.M.1
Su, Z.2
Flexner, C.3
Hughes, M.D.4
Skolnik, P.R.5
Wilkin, T.J.6
Gross, R.7
Krambrink, A.8
Coakley, E.9
Greaves, W.L.10
Zolopa, A.11
Reichman, R.12
Godfrey, C.13
Hirsch, M.14
Kuritzkes, D.R.15
-
18
-
-
34848868199
-
Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4
-
Huang, C. C., S. N. Lam, P. Acharya, M. Tang, S. H. Xiang, S. S. Hussan, R. L. Stanfield, J. Robinson, J. Sodroski, I. A. Wilson, R. Wyatt, C. A. Bewley, and P. D. Kwong. 2007. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317:1930-1934.
-
(2007)
Science
, vol.317
, pp. 1930-1934
-
-
Huang, C.C.1
Lam, S.N.2
Acharya, P.3
Tang, M.4
Xiang, S.H.5
Hussan, S.S.6
Stanfield, R.L.7
Robinson, J.8
Sodroski, J.9
Wilson, I.A.10
Wyatt, R.11
Bewley, C.A.12
Kwong, P.D.13
-
19
-
-
70350316187
-
A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains
-
Johnston, S. H., M. A. Lobritz, S. Nguyen, K. Lassen, S. Delair, F. Posta, Y. J. Bryson, E. J. Arts, T. Chou, and B. Lee. 2009. A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains. J. Virol. 83:11016-11026.
-
(2009)
J. Virol.
, vol.83
, pp. 11016-11026
-
-
Johnston, S.H.1
Lobritz, M.A.2
Nguyen, S.3
Lassen, K.4
Delair, S.5
Posta, F.6
Bryson, Y.J.7
Arts, E.J.8
Chou, T.9
Lee, B.10
-
20
-
-
0034608195
-
Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4
-
Kajumo, F., D. A. Thompson, Y. Guo, and T. Dragic. 2000. Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4. Virology 271:240-247.
-
(2000)
Virology
, vol.271
, pp. 240-247
-
-
Kajumo, F.1
Thompson, D.A.2
Guo, Y.3
Dragic, T.4
-
21
-
-
62949113396
-
Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: Detection of aplaviroc resistance requires clonal analysis of envelope
-
Kitrinos, K. M., H. Amrine-Madsen, D. M. Irlbeck, J. M. Word, and J. F. Demarest. 2009. Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope. Antimicrob. Agents Chemother. 53:1124-1131.
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 1124-1131
-
-
Kitrinos, K.M.1
Amrine-Madsen, H.2
Irlbeck, D.M.3
Word, J.M.4
Demarest, J.F.5
-
22
-
-
12144289333
-
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor
-
Kuhmann, S. E., P. Pugach, K. J. Kunstman, J. Taylor, R. L. Stanfield, A. Snyder, J. M. Strizki, J. Riley, B. M. Baroudy, I. A. Wilson, B. T. Korber, S. M. Wolinsky, and J. P. Moore. 2004. Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor. J. Virol. 78:2790-2807.
-
(2004)
J. Virol.
, vol.78
, pp. 2790-2807
-
-
Kuhmann, S.E.1
Pugach, P.2
Kunstman, K.J.3
Taylor, J.4
Stanfield, R.L.5
Snyder, A.6
Strizki, J.M.7
Riley, J.8
Baroudy, B.M.9
Wilson, I.A.10
Korber, B.T.11
Wolinsky, S.M.12
Moore, J.P.13
-
23
-
-
65549140728
-
HIV-1 entry inhibitors: An overview
-
Kuritzkes, D. R. 2009. HIV-1 entry inhibitors: an overview. Curr. Opin. HIV AIDS 4:82-87.
-
(2009)
Curr. Opin. HIV AIDS
, vol.4
, pp. 82-87
-
-
Kuritzkes, D.R.1
-
24
-
-
0032543307
-
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
-
Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
-
(1998)
Nature
, vol.393
, pp. 648-659
-
-
Kwong, P.D.1
Wyatt, R.2
Robinson, J.3
Sweet, R.W.4
Sodroski, J.5
Hendrickson, W.A.6
-
25
-
-
34548434773
-
V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies
-
Laakso, M. M., F. H. Lee, B. Haggarty, C. Agrawal, K. M. Nolan, M. Biscone, J. Romano, A. P. Jordan, G. J. Leslie, E. G. Meissner, L. Su, J. A. Hoxie, and R. W. Doms. 2007. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies. PLoS Pathog. 3:e117.
-
(2007)
PLoS Pathog.
, vol.3
-
-
Laakso, M.M.1
Lee, F.H.2
Haggarty, B.3
Agrawal, C.4
Nolan, K.M.5
Biscone, M.6
Romano, J.7
Jordan, A.P.8
Leslie, G.J.9
Meissner, E.G.10
Su, L.11
Hoxie, J.A.12
Doms, R.W.13
-
26
-
-
0035036358
-
HIV fusion and its inhibition
-
LaBranche, C. C., G. Galasso, J. P. Moore, D. P. Bolognesi, M. S. Hirsch, and S. M. Hammer. 2001. HIV fusion and its inhibition. Antiviral Res. 50:95-115.
-
(2001)
Antiviral Res.
, vol.50
, pp. 95-115
-
-
LaBranche, C.C.1
Galasso, G.2
Moore, J.P.3
Bolognesi, D.P.4
Hirsch, M.S.5
Hammer, S.M.6
-
27
-
-
25844450042
-
Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults
-
Lalezari, J., M. Thompson, P. Kumar, P. Piliero, R. Davey, K. Patterson, A. Shachoy-Clark, K. Adkison, J. Demarest, Y. Lou, M. Berrey, and S. Piscitelli. 2005. Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults. AIDS 19:1443-1448. (Pubitemid 41400688)
-
(2005)
AIDS
, vol.19
, Issue.14
, pp. 1443-1448
-
-
Lalezari, J.1
Thompson, M.2
Kumar, P.3
Piliero, P.4
Davey, R.5
Patterson, K.6
Shachoy-Clark, A.7
Adkison, K.8
Demarest, J.9
Lou, Y.10
Berrey, M.11
Piscitelli, S.12
-
28
-
-
0033515588
-
Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
-
Lee, B., M. Sharron, C. Blanpain, B. J. Doranz, J. Vakili, P. Setoh, E. Berg, G. Liu, H. R. Guy, S. R. Durell, M. Parmentier, C. N. Chang, K. Price, M. Tsang, and R. W. Doms. 1999. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J. Biol. Chem. 274:9617-9626.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 9617-9626
-
-
Lee, B.1
Sharron, M.2
Blanpain, C.3
Doranz, B.J.4
Vakili, J.5
Setoh, P.6
Berg, E.7
Liu, G.8
Guy, H.R.9
Durell, S.R.10
Parmentier, M.11
Chang, C.N.12
Price, K.13
Tsang, M.14
Doms, R.W.15
-
29
-
-
0033609149
-
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
-
Lee, B., M. Sharron, L. J. Montaner, D. Weissman, and R. W. Doms. 1999. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. U. S. A. 96:5215-5220.
-
(1999)
Proc. Natl. Acad. Sci. U. S. A.
, vol.96
, pp. 5215-5220
-
-
Lee, B.1
Sharron, M.2
Montaner, L.J.3
Weissman, D.4
Doms, R.W.5
-
30
-
-
33744990609
-
Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys
-
Letvin, N. L., J. R. Mascola, Y. Sun, D. A. Gorgone, A. P. Buzby, L. Xu, Z. Y. Yang, B. Chakrabarti, S. S. Rao, J. E. Schmitz, D. C. Montefiori, B. R. Barker, F. L. Bookstein, and G. J. Nabel. 2006. Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 312:1530-1533.
-
(2006)
Science
, vol.312
, pp. 1530-1533
-
-
Letvin, N.L.1
Mascola, J.R.2
Sun, Y.3
Gorgone, D.A.4
Buzby, A.P.5
Xu, L.6
Yang, Z.Y.7
Chakrabarti, B.8
Rao, S.S.9
Schmitz, J.E.10
Montefiori, D.C.11
Barker, B.R.12
Bookstein, F.L.13
Nabel, G.J.14
-
31
-
-
33744954776
-
Structural and molecular interactions of CCR5 inhibitors with CCR5
-
Maeda, K., D. Das, H. Ogata-Aoki, H. Nakata, T. Miyakawa, Y. Tojo, R. Norman, Y. Takaoka, J. Ding, G. F. Arnold, E. Arnold, and H. Mitsuya. 2006. Structural and molecular interactions of CCR5 inhibitors with CCR5. J. Biol. Chem. 281:12688-12698.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 12688-12698
-
-
Maeda, K.1
Das, D.2
Ogata-Aoki, H.3
Nakata, H.4
Miyakawa, T.5
Tojo, Y.6
Norman, R.7
Takaoka, Y.8
Ding, J.9
Arnold, G.F.10
Arnold, E.11
Mitsuya, H.12
-
32
-
-
48649101575
-
Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: Insights into the mechanism of allosteric inhibition
-
Maeda, K., D. Das, P. D. Yin, K. Tsuchiya, H. Ogata-Aoki, H. Nakata, R. B. Norman, L. A. Hackney, Y. Takaoka, and H. Mitsuya. 2008. Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition. J. Mol. Biol. 381:956-974.
-
(2008)
J. Mol. Biol.
, vol.381
, pp. 956-974
-
-
Maeda, K.1
Das, D.2
Yin, P.D.3
Tsuchiya, K.4
Ogata-Aoki, H.5
Nakata, H.6
Norman, R.B.7
Hackney, L.A.8
Takaoka, Y.9
Mitsuya, H.10
-
33
-
-
20644453529
-
Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D)
-
Marozsan, A. J., S. E. Kuhmann, T. Morgan, C. Herrera, E. Rivera-Troche, S. Xu, B. M. Baroudy, J. Strizki, and J. P. Moore. 2005. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D). Virology 338:182-199.
-
(2005)
Virology
, vol.338
, pp. 182-199
-
-
Marozsan, A.J.1
Kuhmann, S.E.2
Morgan, T.3
Herrera, C.4
Rivera-Troche, E.5
Xu, S.6
Baroudy, B.M.7
Strizki, J.8
Moore, J.P.9
-
34
-
-
0032080906
-
Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood
-
Mo, H., S. Monard, H. Pollack, J. Ip, G. Rochford, L. Wu, J. Hoxie, W. Borkowsky, D. D. Ho, and J. P. Moore. 1998. Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood. AIDS Res. Hum. Retroviruses 14:607-617.
-
(1998)
AIDS Res. Hum. Retroviruses
, vol.14
, pp. 607-617
-
-
Mo, H.1
Monard, S.2
Pollack, H.3
Ip, J.4
Rochford, G.5
Wu, L.6
Hoxie, J.7
Borkowsky, W.8
Ho, D.D.9
Moore, J.P.10
-
35
-
-
0141814730
-
The entry of entry inhibitors: A fusion of science and medicine
-
Moore, J. P., and R. W. Doms. 2003. The entry of entry inhibitors: a fusion of science and medicine. Proc. Natl. Acad. Sci. U. S. A. 100:10598-10602.
-
(2003)
Proc. Natl. Acad. Sci. U. S. A.
, vol.100
, pp. 10598-10602
-
-
Moore, J.P.1
Doms, R.W.2
-
36
-
-
70450170953
-
Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist vicriviroc
-
Ogert, R. A., L. Ba, Y. Hou, C. Buontempo, P. Qiu, J. Duca, N. Murgolo, P. Buontempo, R. Ralston, and J. A. Howe. 2009. Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist vicriviroc. J. Virol. 83:12151-12163.
-
(2009)
J. Virol.
, vol.83
, pp. 12151-12163
-
-
Ogert, R.A.1
Ba, L.2
Hou, Y.3
Buontempo, C.4
Qiu, P.5
Duca, J.6
Murgolo, N.7
Buontempo, P.8
Ralston, R.9
Howe, J.A.10
-
37
-
-
40849085150
-
Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120
-
Ogert, R. A., L. Wojcik, C. Buontempo, L. Ba, P. Buontempo, R. Ralston, J. Strizki, and J. A. Howe. 2008. Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120. Virology 373:387-399.
-
(2008)
Virology
, vol.373
, pp. 387-399
-
-
Ogert, R.A.1
Wojcik, L.2
Buontempo, C.3
Ba, L.4
Buontempo, P.5
Ralston, R.6
Strizki, J.7
Howe, J.A.8
-
38
-
-
34548413609
-
Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection
-
Okoye, A., M. Meier-Schellersheim, J. M. Brenchley, S. I. Hagen, J. M. Walker, M. Rohankhedkar, R. Lum, J. B. Edgar, S. L. Planer, A. Legasse, A. W. Sylwester, M. Piatak, Jr., J. D. Lifson, V. C. Maino, D. L. Sodora, D. C. Douek, M. K. Axthelm, Z. Grossman, and L. J. Picker. 2007. Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J. Exp. Med. 204:2171-2185.
-
(2007)
J. Exp. Med.
, vol.204
, pp. 2171-2185
-
-
Okoye, A.1
Meier-Schellersheim, M.2
Brenchley, J.M.3
Hagen, S.I.4
Walker, J.M.5
Rohankhedkar, M.6
Lum, R.7
Edgar, J.B.8
Planer, S.L.9
Legasse, A.10
Sylwester, A.W.11
Piatak Jr., M.12
Lifson, J.D.13
Maino, V.C.14
Sodora, D.L.15
Douek, D.C.16
Axthelm, M.K.17
Grossman, Z.18
Picker, L.J.19
-
39
-
-
34047271098
-
HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry
-
Pugach, P., A. J. Marozsan, T. J. Ketas, E. L. Landes, J. P. Moore, and S. E. Kuhmann. 2007. HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry. Virology 361:212-228.
-
(2007)
Virology
, vol.361
, pp. 212-228
-
-
Pugach, P.1
Marozsan, A.J.2
Ketas, T.J.3
Landes, E.L.4
Moore, J.P.5
Kuhmann, S.E.6
-
40
-
-
64849083122
-
Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities
-
Pugach, P., N. Ray, P. J. Klasse, T. J. Ketas, E. Michael, R. W. Doms, B. Lee, and J. P. Moore. 2009. Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities. Virology 387:296-302.
-
(2009)
Virology
, vol.387
, pp. 296-302
-
-
Pugach, P.1
Ray, N.2
Klasse, P.J.3
Ketas, T.J.4
Michael, E.5
Doms, R.W.6
Lee, B.7
Moore, J.P.8
-
41
-
-
0031900659
-
Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- And dualtropic isolates of human immunodeficiency virus type 1
-
Rabut, G. E., J. A. Konner, F. Kajumo, J. P. Moore, and T. Dragic. 1998. Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1. J. Virol. 72:3464-3468.
-
(1998)
J. Virol.
, vol.72
, pp. 3464-3468
-
-
Rabut, G.E.1
Konner, J.A.2
Kajumo, F.3
Moore, J.P.4
Dragic, T.5
-
42
-
-
0034690683
-
Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120
-
Rizzuto, C., and J. Sodroski. 2000. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120. AIDS Res. Hum. Retroviruses 16:741-749.
-
(2000)
AIDS Res. Hum. Retroviruses
, vol.16
, pp. 741-749
-
-
Rizzuto, C.1
Sodroski, J.2
-
43
-
-
0032546952
-
A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
-
Rizzuto, C. D., R. Wyatt, N. Hernandez-Ramos, Y. Sun, P. D. Kwong, W. A. Hendrickson, and J. Sodroski. 1998. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949-1953.
-
(1998)
Science
, vol.280
, pp. 1949-1953
-
-
Rizzuto, C.D.1
Wyatt, R.2
Hernandez-Ramos, N.3
Sun, Y.4
Kwong, P.D.5
Hendrickson, W.A.6
Sodroski, J.7
-
44
-
-
16044365432
-
Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity
-
Rucker, J., M. Samson, B. J. Doranz, F. Libert, J. F. Berson, Y. Yi, R. J. Smyth, R. G. Collman, C. C. Broder, G. Vassart, R. W. Doms, and M. Parmentier. 1996. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87:437-446.
-
(1996)
Cell
, vol.87
, pp. 437-446
-
-
Rucker, J.1
Samson, M.2
Doranz, B.J.3
Libert, F.4
Berson, J.F.5
Yi, Y.6
Smyth, R.J.7
Collman, R.G.8
Broder, C.C.9
Vassart, G.10
Doms, R.W.11
Parmentier, M.12
-
45
-
-
0033554726
-
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
-
Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712. (Pubitemid 129515761)
-
(1999)
Nature
, vol.401
, Issue.6754
, pp. 708-712
-
-
Sallusto, F.1
Lenig, D.2
Forster, R.3
Lipp, M.4
Lanzavecchia, A.5
-
46
-
-
33646514864
-
Interaction of small molecule inhibitors of HIV-1 entry with CCR5
-
Seibert, C., W. Ying, S. Gavrilov, F. Tsamis, S. E. Kuhmann, A. Palani, J. R. Tagat, J. W. Clader, S. W. McCombie, B. M. Baroudy, S. O. Smith, T. Dragic, J. P. Moore, and T. P. Sakmar. 2006. Interaction of small molecule inhibitors of HIV-1 entry with CCR5. Virology 349:41-54.
-
(2006)
Virology
, vol.349
, pp. 41-54
-
-
Seibert, C.1
Ying, W.2
Gavrilov, S.3
Tsamis, F.4
Kuhmann, S.E.5
Palani, A.6
Tagat, J.R.7
Clader, J.W.8
McCombie, S.W.9
Baroudy, B.M.10
Smith, S.O.11
Dragic, T.12
Moore, J.P.13
Sakmar, T.P.14
-
47
-
-
0035940445
-
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo
-
Strizki, J. M., S. Xu, N. E. Wagner, L. Wojcik, J. Liu, Y. Hou, M. Endres, A. Palani, S. Shapiro, J. W. Clader, W. J. Greenlee, J. R. Tagat, S. McCombie, K. Cox, A. B. Fawzi, C. C. Chou, C. Pugliese-Sivo, L. Davies, M. E. Moreno, D. D. Ho, A. Trkola, C. A. Stoddart, J. P. Moore, G. R. Reyes, and B. M. Baroudy. 2001. SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 98:12718-12723.
-
(2001)
Proc. Natl. Acad. Sci. U. S. A.
, vol.98
, pp. 12718-12723
-
-
Strizki, J.M.1
Xu, S.2
Wagner, N.E.3
Wojcik, L.4
Liu, J.5
Hou, Y.6
Endres, M.7
Palani, A.8
Shapiro, S.9
Clader, J.W.10
Greenlee, W.J.11
Tagat, J.R.12
McCombie, S.13
Cox, K.14
Fawzi, A.B.15
Chou, C.C.16
Pugliese-Sivo, C.17
Davies, L.18
Moreno, M.E.19
Ho, D.D.20
Trkola, A.21
Stoddart, C.A.22
Moore, J.P.23
Reyes, G.R.24
Baroudy, B.M.25
more..
-
48
-
-
76449113232
-
HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry
-
Tilton, J. C., H. Amrine-Madsen, J. L. Miamidian, K. M. Kitrinos, J. Pfaff, J. F. Demarest, N. Ray, J. L. Jeffrey, C. C. Labranche, and R. W. Doms. 2010. HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry. AIDS Res. Hum. Retroviruses. 26:13-24.
-
(2010)
AIDS Res. Hum. Retroviruses.
, vol.26
, pp. 13-24
-
-
Tilton, J.C.1
Amrine-Madsen, H.2
Miamidian, J.L.3
Kitrinos, K.M.4
Pfaff, J.5
Demarest, J.F.6
Ray, N.7
Jeffrey, J.L.8
Labranche, C.C.9
Doms, R.W.10
-
49
-
-
73549092165
-
Entry inhibitors in the treatment of HIV-1 infection
-
Tilton, J. C., and R. W. Doms. 2010. Entry inhibitors in the treatment of HIV-1 infection. Antiviral Res. 85:91-100.
-
(2010)
Antiviral Res.
, vol.85
, pp. 91-100
-
-
Tilton, J.C.1
Doms, R.W.2
-
50
-
-
16144365317
-
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
-
Trkola, A., T. Dragic, J. Arthos, J. M. Binlay, W. C. Olson, G. P. Allaway, C. Cheng-Meyer, J. Robinson, P. J. Maddon, and J. P. Moore. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384:184-187.
-
(1996)
Nature
, vol.384
, pp. 184-187
-
-
Trkola, A.1
Dragic, T.2
Arthos, J.3
Binlay, J.M.4
Olson, W.C.5
Allaway, G.P.6
Cheng-Meyer, C.7
Robinson, J.8
Maddon, P.J.9
Moore, J.P.10
-
51
-
-
0037039380
-
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use
-
Trkola, A., S. E. Kuhmann, J. M. Strizki, E. Maxwell, T. Ketas, T. Morgan, P. Pugach, S. Xu, L. Wojcik, J. Tagat, A. Palani, S. Shapiro, J. W. Clader, S. McCombie, G. R. Reyes, B. M. Baroudy, and J. P. Moore. 2002. HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use. Proc. Natl. Acad. Sci. U. S. A. 99:395-400.
-
(2002)
Proc. Natl. Acad. Sci. U. S. A.
, vol.99
, pp. 395-400
-
-
Trkola, A.1
Kuhmann, S.E.2
Strizki, J.M.3
Maxwell, E.4
Ketas, T.5
Morgan, T.6
Pugach, P.7
Xu, S.8
Wojcik, L.9
Tagat, J.10
Palani, A.11
Shapiro, S.12
Clader, J.W.13
McCombie, S.14
Reyes, G.R.15
Baroudy, B.M.16
Moore, J.P.17
-
52
-
-
0037404511
-
Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry
-
Tsamis, F., S. Gavrilov, F. Kajumo, C. Seibert, S. Kuhmann, T. Ketas, A. Trkola, A. Palani, J. W. Clader, J. R. Tagat, S. McCombie, B. Baroudy, J. P. Moore, T. P. Sakmar, and T. Dragic. 2003. Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry. J. Virol. 77:5201-5208.
-
(2003)
J. Virol.
, vol.77
, pp. 5201-5208
-
-
Tsamis, F.1
Gavrilov, S.2
Kajumo, F.3
Seibert, C.4
Kuhmann, S.5
Ketas, T.6
Trkola, A.7
Palani, A.8
Clader, J.W.9
Tagat, J.R.10
McCombie, S.11
Baroudy, B.12
Moore, J.P.13
Sakmar, T.P.14
Dragic, T.15
-
53
-
-
49149118151
-
In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject
-
Tsibris, A. M., M. Sagar, R. M. Gulick, Z. Su, M. Hughes, W. Greaves, M. Subramanian, C. Flexner, F. Giguel, K. E. Leopold, E. Coakley, and D. R. Kuritzkes. 2008. In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject. J. Virol. 82:8210-8214.
-
(2008)
J. Virol.
, vol.82
, pp. 8210-8214
-
-
Tsibris, A.M.1
Sagar, M.2
Gulick, R.M.3
Su, Z.4
Hughes, M.5
Greaves, W.6
Subramanian, M.7
Flexner, C.8
Giguel, F.9
Leopold, K.E.10
Coakley, E.11
Kuritzkes, D.R.12
-
54
-
-
15744391870
-
The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor
-
Watson, C., S. Jenkinson, W. Kazmierski, and T. Kenakin. 2005. The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor. Mol. Pharmacol. 67:1268-1282.
-
(2005)
Mol. Pharmacol.
, vol.67
, pp. 1268-1282
-
-
Watson, C.1
Jenkinson, S.2
Kazmierski, W.3
Kenakin, T.4
-
55
-
-
33646443202
-
Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir
-
Westby, M., M. Lewis, J. Whitcomb, M. Youle, A. L. Pozniak, I. T. James, T. M. Jenkins, M. Perros, and E. van der Ryst. 2006. Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir. J. Virol. 80:4909-4920.
-
(2006)
J. Virol.
, vol.80
, pp. 4909-4920
-
-
Westby, M.1
Lewis, M.2
Whitcomb, J.3
Youle, M.4
Pozniak, A.L.5
James, I.T.6
Jenkins, T.M.7
Perros, M.8
Van Der Ryst, E.9
-
56
-
-
33847237614
-
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry
-
Westby, M., C. Smith-Burchnell, J. Mori, M. Lewis, M. Mosley, M. Stockdale, P. Dorr, G. Ciaramella, and M. Perros. 2007. Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry. J. Virol. 81:2359-2371.
-
(2007)
J. Virol.
, vol.81
, pp. 2359-2371
-
-
Westby, M.1
Smith-Burchnell, C.2
Mori, J.3
Lewis, M.4
Mosley, M.5
Stockdale, M.6
Dorr, P.7
Ciaramella, G.8
Perros, M.9
|